宜昌招聘

Major Accountabilities (Describe the main results of the job to be achieved )

1. Accounting
? Manage the Accounts Payable processing.
? Interface with eShop to ensure all GR and IR are recorded.
? Interface with eTravel to make sure all claims and advances are posted to SAP.
? Verify VAT invoices via tax system.
? Run and analyse GR/IR and AP aging report
? Perform automatic and manual clearing of GR/IR and AP account.
? The assigned area of responsibility is dependent on the company needs and can be changed as needed. The area of responsibility shall be rotated on a regular base to enable all FRA specialists to become each other backup as well as to facilitate the development of the finance function in general.
? Act as deputy for at least on other FRA specialist

2. Controls
? Assist FRA Manager to:
o Set and verify the internal controls of the Finance function, ensuring compliance and audit ability with Sarbanes Oxley Act (SOX) and internal company guidelines.
o Control and verify the compliance with the company’s signature authorisation regulations, both manual and system based.
o To complete the monthly reporting in FCRS

3. Statutory Compliance
? Ensure the Company and its systems meet all regulatory and statutory requirements, like PRC Accounting Guidelines, SAFE Regulations, Tax Legislation.

4. Finance Operating Procedures
? Ensure that all Finance procedures are strictly adhered to within the Company jointly with the FRA Manager.
? Regular review and update of finance procedures.


Experience: Chinese and English essential

? At least five years experience in financial ledgers
? Ability to communicate effectively with team members, suppliers, customers and cross function associates.
? Technical understanding of VAT and Local / State Tax legislation and guidelines.
? Strong organizational ability and results driven.

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。